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Rationale: To address unmet needs, electronic messages to support person-centred goal attainment 
and secondary prevention may avoid hospital presentations/readmissions after stroke, but evidence 
is limited.
Hypothesis:  Compared to control participants, there will be a 10% lower proportion of intervention 
participants who represent to hospital (emergency/admission) within 90 days of randomisation.
Methods and design: Multicentre, double-blind, randomised controlled trial with intention-to-treat 
analysis. The intervention group receives 12 weeks of personalised, goal-centred and administrative 
electronic messages, while the control group only receive administrative messages. The trial 
includes a process evaluation, assessment of treatment fidelity and an economic evaluation. 
Participants: Confirmed stroke (modified Rankin Score: 0-4), aged ≥18 years with internet/mobile 
phone access, discharged directly home from hospital. 
Randomisation: 1:1 computer-generated, stratified by age and baseline disability.
Outcomes Assessments: Collected at 90 days and 12 months following randomisation. 
Outcomes: Primary: Hospital emergency presentations/admissions within 90 days of randomisation. 
Secondary outcomes include goal attainment, self-efficacy, mood, unmet needs, disability, quality-
of-life, recurrent stroke/cardiovascular events/deaths at 90 days and 12 months, and death and cost-
effectiveness at 12 months. 
Sample size: To test our primary hypothesis, we estimated a sample size of 890 participants (445 
per group) with 80% power and two-tailed significance threshold of α=0.05. Given uncertainty for 
the effect size of this novel intervention, the sample size will be adaptively re-estimated when 
outcomes for n=668 are obtained, with maximum sample capped at 1100.
Discussion: We will provide new evidence on the potential effectiveness, implementation and cost-
effectiveness of a tailored eHealth intervention for survivors of stroke.
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Many survivors of stroke feel inadequately prepared for life back in the community with many 
reporting unmet needs.1 Discharge planning should address the individual’s needs with reference to 
their usual activities, home environment, personal concerns and stroke risk.2 Innovative, accessible, 
support and education programs that align with survivor recovery and lifestyle goals are needed. 
Short message services (SMS) and eHealth tools have been proposed to support behaviour change 
and disease management.3 However, the effectiveness of tailored eHealth messaging for survivors 
after stroke has not been comprehensively assessed, with evidence limited to medication adherence, 
or to a subgroup of those with hypertension or depression.4 In a recently published three-arm trial 
(n=400) of a one-to-one facilitated intervention with a focus on “talking therapy” to improve self-
management and quality of life in a similar population (recently discharged directly to the 
community after stroke), the intervention was shown to be effective.5 This latter study, provides 
some support for the need and potential effectiveness of patient-centred support programs after 
stroke, that has complementary elements to our approach. 
We have co-designed the iVERVE (inspiring Virtual Enabled Resources following Vascular Events) 
intervention with leading stroke academics, clinicians, telecommunication engineers, and consumer 
representatives to establish an innovative, electronic self-management intervention, supporting 
person-centred goal attainment and secondary prevention after stroke (see Supplemental file).4 In 
our early Phase I randomised controlled trial (RCT) in people with chronic stroke, we had >80% 
retention, and acquired evidence to refine processes for goal-setting and assigning messages.6 In 
Phase II we tested the feasibility of this protocol (n=37, completed 2019) to inform the final design 
of this Phase III RCT of the Recovery-focused Community support to Avoid readmissions and 
improve Participation after Stroke (ReCAPS). This multicomponent intervention comprises: 1) 
standardised person-centred goalsetting (5 dimensions and 34 sub-items); and 2) personalised 
electronic messaging (>1300 available) tailored to the individualised goals.6 
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This is a prospective, parallel two-group, double-blind, multisite, Phase III randomised trial with 
blinded outcome assessments and intention-to-treat analysis. The design includes a process 
evaluation, assessment of treatment fidelity and an economic evaluation. Trial assessment periods 
(figure 1), baseline and outcome measures are outlined in Supplemental Table I.
Aims and hypotheses
The primary aim of the study is to compare the effectiveness of ReCAPS to standard care in 
participants with stroke. The primary endpoint is the proportion of participants who present to 
hospital (emergency/admission) within 90 days of study randomisation (Day 90) and the secondary 
endpoints include goal attainment, self-efficacy, mood, disability and stroke/cardiovascular 
events/death. Cost effectiveness will also be calculated.
Primary hypothesis: Compared to control participants, there will be a 10% lower proportion of 
intervention participants who represent to hospital (emergency/admission) within 90 days of 
randomisation.
Study population
Individuals admitted with acute stroke attending Australian public hospitals.
Inclusion criteria
Patients ≥18 years with capacity to consent, a confirmed diagnosis of stroke, discharged directly 
home within 10 to 14 days of admission and a modified Rankin score7 (mRS) 0-4. Patients require 
the ability to communicate in English and have access to and use the internet and/or smart phone 
technology.
Exclusions: Patients discharged to inpatient rehabilitation, those with an inability to communicate 
their goals, patients with a poor prognosis (<90 days) or requiring major surgery within 12 weeks of 
discharge. 
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Recruitment: Hospital clinicians from up to 16 hospitals will screen for eligibility, obtain consent 
and collect baseline data. Participants are told that they will be randomly allocated to one of two 
groups and, to maintain blinding, details of the intervention are explained in general e.g., ‘you will 
receive one of the two support programs aimed at helping you after your stroke…and will involve 
you receiving information via SMS or email during a period of 12 weeks’. Groups are not informed 
about the number of messages they can expect to receive and are unaware that only the intervention 
group have their messages tailored to their goals.
Trial Procedures
Baseline assessments: Participants have their baseline assessments completed either in hospital, or 
shortly after discharge by phone, with the hospital clinicians or clinician researchers (Figure 1). All 
participants receive the same structured person-centred goal-setting procedure using the ReCAPS 
standardised goal-setting menu to identify between 2 and 5 goals to achieve over 12 weeks.
Randomisation and blinding: Within 7-14 days of discharge, participants are contacted by a 
trained clinician researcher to complete a validated discharge satisfaction survey and unmet needs 
questionnaire (Supplemental Table 1). The participant is then supported to restructure their stated 
goals to ensure they meet SMART requirements (Specific, Measurable, Achievable, Realistic and 
Time-bound)8, if required. Once completed an affirmation to continue is requested, then online 
randomisation (1:1 ratio) occurs using REDCap (Research Electronic Data Capture; a secure web-
based data management system),9 stratified by age (<65 or 65+ years) and disability (baseline mRS 
0-2 or 3-4). In this manner, hospital clinicians are masked to group allocation as randomisation 
occurs after discharge.
Intervention
Intervention components are summarised in Supplemental Table I. Participants review and prioritise 
their goals with the clinician researcher. They are given the opportunity to revise and add new goals 
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to a maximum of five, if original goals are no longer relevant. The responses from the unmet needs 
questionnaire may be used in revising or prioritising participant goals, or in tailoring relevant 
messages. The SMS messages are then scheduled to be sent to participants using iVERVE,4 
commencing within 3-4 days and continuing over 12-weeks. Participants receive a message about 
using embedded hyperlinks in their messages to access relevant additional online information. 
Messages are aligned to each participants goal, and the priority specified by them. Messages are 
gradually introduced for each goal. In the first week, only messages related to their top priority goal 
are sent and the number of messages sent over 12 weeks varies according to the number of goals. 
Intervention participants will receive between 4-7 personalised messages/week in addition to 
regular administrative and motivational messages about progress, equating to approximately one 
message/day. Participants are able to reply using a “STOP” message if they no longer wish to 
receive messages. They can also respond to questions in the messages or can ask questions/make 
comments4 which are responded to within 72 hours by the research team.
Control arm
Participants are unable to add additional goals after baseline, but can drop an existing goal if no 
longer relevant. Consistent with the intervention group, they receive similar administrative 
messages. They also receive several administrative messages related to their follow-up 
appointments. The control group do not receive messages about using hyperlinks or receive 
messages of motivation about their progress. Both intervention and control groups receive a 
message in the first week with a link to the Stroke Foundation (Australia) website 
(https://strokefoundation.org.au/) for support. 
Outcome assessments: Outcomes are collected at 90 days and 12 months from randomisation via a 
scripted telephone conversation or video call with a trained research outcome assessor. To remain 
blind to participant group allocation, these outcome assessors are not involved in the telephone 
contact at 7-14 days. To facilitate the assessment, participants receive a copy of the health surveys, 
electronically or by post, 1-2 weeks in advance. All trial data are captured using REDCap9 software. 
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The primary outcome is the difference in the proportion of intervention and control group 
participants presenting to hospital (emergency department or admission) within 90 days of 
randomisation. Hospital presentations are self-reported by participants, and verified from medical 
records and also validated using linked emergency and hospital administrative data held by 
government.
Secondary outcomes: These are assessed at 90 days and 12 months post-randomisation and include 
standardised health outcome and resource-use measures including goal attainment, self-efficacy, 
anxiety and depression, hospital contacts, quality of life, education attainment, costs and a 
composite outcome of recurrent stroke, cardiovascular events or deaths (Supplemental Table I).
Data Monitoring 
An independent Data Safety and Monitoring Committee (DSMC) will review adverse events of 
interest (emergency presentations, falls, car accident/s [i.e. if participant driving]) reported from 
consent to 90 days post randomisation. Serious Adverse Events (SAEs) will be reported for 12 
months from time of consent. A medical monitor has been appointed to independently adjudicate 
SAE diagnoses and their relationship to the trial intervention. 
Sample size
This effectiveness trial is powered to detect a 10% difference in the proportion of participants with a 
hospital presentation (emergency presentation/admission) within 90 days of randomisation (34% 
versus 24%).10 To achieve 80% power, with a significance threshold of α=0.05 two-tailed, we 
require 342 participants per group. This is a conservative estimate based on preliminary data from 
the Australian Stroke Clinical Registry (AuSCR) linked to hospital emergency and admissions data 
in four states (Victoria, New South Wales, Western Australia and Queensland) and applying our 
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study inclusion criteria.11 To account for the possibility that up to 30% of participants may drop out, 
die or decline consent to provide linked data for the ED presentations/hospital admissions outcome, 
our pre-planned target sample size is 890 (445 per group). This sample size is also estimated to 
provide >80% power to detect statistically significant differences between groups for secondary 
outcomes including goal attainment. Nonetheless, given the indirect evidence used for the effect 
size, an adaptive sample size estimation procedure will be undertaken as per the “promising zone” 
methods of Mehta and Pocock12 once the outcomes for n=668 participants are obtained, with the 
maximum sample size capped at 1100.
Statistical analysis
A statistical analysis plan will be published before final data collection. A statistician blind to group 
allocation will oversee data analyses. 
Primary analysis: The primary outcome will be analysed using intention-to-treat principles. To 
investigate whether the trial intervention reduces the proportion of participants with at least one 
hospital presentation (emergency presentation or admission) within 90 days post randomisation, we 
will use random effects logistic regression. The primary outcome will be the dependent variable, 
group allocation the independent variable and hospital the random effect (to account for potential 
heterogeneity in treatment effects). 
Secondary analyses: A per-protocol analysis is planned for those who completed 80% or more of the 
intervention to which they were randomised (i.e., remained in the study for at least 10 weeks). 
Descriptive statistics will be used to compare outcome measures for each group. Multivariable 
statistical models (as appropriate for the outcome measure, generalised linear, logistic, quantile or 
negative binomial regression) will be used. Secondary outcomes will be the dependent variables, 
group allocation the independent variable and the baseline scores for the secondary outcomes will 
serve as the covariates.
Missing data: Treatment of missing data will be based on the satisfying missing at random 
assumptions, and will be based on the intention to treat strategy as per White et al.13 
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Process evaluation: A separate protocol for the process evaluation will be published. It will be 
based on the Medical Research Council guidance for complex interventions.18 It will include 
researcher and hospital staff interview guides, and satisfaction survey analysis methods. The 
evaluation will capture fidelity to describe whether the intervention was delivered as intended.14 
The REAIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework will 
be used when reporting process evaluation results.15
Economic evaluation: We will use a societal perspective that includes collecting data on direct 
health sector (hospitalisations, general practice or allied health visits), out-of-pocket, and indirect 
costs associated with workforce participation or household productivity. Self-reported data are 
supplemented by obtaining participant consent to linked administrative data with hospitalisations, 
emergency department presentations, medical office visits and medication dispensing records for 12 
months before admission (to adjust for pre-stroke service use), and 12 months post randomisation. 
An incremental cost-effectiveness ratio (ICER) will be calculated as the net cost/Quality Adjusted 
Life Year (QALY; derived from the European Quality of Life-5 Dimensions EuroQoL-5D-3L16 
gained <$50,000 (willingness to pay threshold). Sensitivity and uncertainty analyses will be 
performed to assess the robustness of results.
Study organization and funding
ReCAPS is an investigator-initiated collaboration sponsored by Monash University.  Funding was 
received from the Victorian government (Victorian Medical Research Acceleration Fund), Monash 
University and the National Health and Medical Research Council (NHMRC: project 1162596). 
The following authors also received research fellowship support from the NHMRC (DAC: 1154273, 
MLH 1141328) and the Heart Foundation, Australia (NAL: 102055)
This trial is registered with Australian New Zealand Clinical Trials Registry 
(ACTRN12618001468213) and approved by Monash Health (2018-16435-22429) and Monash 
University (16435) Human Research Ethics Committee.
Discussion
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This trial will provide important evidence on whether a personalised e-health support package for 
individuals discharged directly home after their stroke is effective in reducing hospital presentations. 
This 5-year trial included a “run-in” feasibility component (Phase II) with 37 participants recruited 
from three hospitals. Processes and procedures were refined for the commencement of the Phase III 
trial with our first patient recruited in August 2019 and 9 hospitals now having recruited over 200 
patients by April 2021. COVID-19 has resulted in recruitment delays. To ensure timely recruitment 
of the necessary sample size  e-consent procedures have been established and we are in the process 
of onboarding four additional hospital sites. The process and economic evaluations will provide 
relevant information for the translation of our trial results. 
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Figure 1 Trial design
mRS: modified Rankin scale, ReCAPS: Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke, 
SMS: short messaging service, SMART: Specific, Measurable, Achievable, Realistic, and Time-bound, T: Time/assessment
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Control group (n=445)
Up to 7 administrative messages sent via 
SMS/email, including a link to the 
Stroke Foundation website
Intervention group (n=445)
• Opportunity to revise/add goals
• Messages assigned and aligned to goals plus 




(within 14 days of 
admission)
Recruitment: clinical staff at participating hospitals
• Screen patients. Consent (paper-based or e-consent) eligible patients (i.e. exclude: mRS>4)
• Baseline assessment (face to face/phone/online/post by clinical staff or clinician researcher if e-consent provided)




Follow-up (phone/video) by central ReCAPS Office (Monash University)
• Discharge satisfaction and unmet needs surveys  
• Goals reviewed, converted to SMART (measurable) goals
Randomisation using inbuilt computer generated program
T2
90 days post 
randomisation
Outcome assessment: telephone interview with blinded outcome assessor
• Primary and secondary outcome measures (online/post/phone/video call)




Outcome assessment: telephone interview with blinded outcome assessor
• Readmissions, recurrent stroke or cardiovascular events, healthcare services use, medications and quality of life
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